Trials / Recruiting
RecruitingNCT04457544
Spontaneous Coronary Artery Dissection National Swiss Registry
Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Dr. Sophie Degrauwe · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse outcomes including myocardial infarction, cardiac arrest, or death. Timely diagnosis of SCAD as well as clinical follow-up are of the essence in this pathology associated with major cardiac adverse outcomes. Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood. In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.
Conditions
Timeline
- Start date
- 2020-08-12
- Primary completion
- 2025-06-30
- Completion
- 2030-06-30
- First posted
- 2020-07-07
- Last updated
- 2022-11-16
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04457544. Inclusion in this directory is not an endorsement.